10x Fund, L.p. - Net Worth and Insider Trading
10x Fund, L.p. Net Worth
The estimated net worth of 10x Fund, L.p. is at least $17 Million dollars as of 2024-11-29. 10x Fund, L.p. is the 10% Owner of Galectin Therapeutics Inc and owns about 6,168,940 shares of Galectin Therapeutics Inc (GALT) stock worth over $17 Million. Details can be seen in 10x Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that 10x Fund, L.p. has not made any transactions after 2022-07-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of 10x Fund, L.p.
10x Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, 10x Fund, L.p. owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of 10x Fund, L.p.’s form 4 insider trades.
Insider Ownership Summary of 10x Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-07-27 | 10 percent owner |
10x Fund, L.p. Latest Holdings Summary
10x Fund, L.p. currently owns a total of 1 stock. 10x Fund, L.p. owns 6,168,940 shares of Galectin Therapeutics Inc (GALT) as of July 27, 2022, with a value of $17 Million.
Latest Holdings of 10x Fund, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-07-27 | 6,168,940 | 2.84 | 17,488,945 |
Holding Weightings of 10x Fund, L.p.
10x Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, 10x Fund, L.p. has made a total of 18 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Galectin Therapeutics Inc is the sale of 10,000 shares on July 27, 2022, which brought 10x Fund, L.p. around $20,900.
Insider Trading History of 10x Fund, L.p.
- 1
10x Fund, L.p. Trading Performance
10x Fund, L.p. Ownership Network
10x Fund, L.p. Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
10x Fund, L.p. is the 10 percent owner of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include director & 10 percent owner Richard E Uihlein , Chief Medical Officer Pol F Boudes , and Chief Financial Officer Jack W Callicutt .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, 10x Fund, L.p. made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 11,800 shares, with a net purchase of 11,800 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
10x Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for 10x Fund, L.p.. You might contact 10x Fund, L.p. via mailing address: 1099 Forest Lake Terrace, Niceville Fl 32578.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
